关注
William R Hiatt
William R Hiatt
Professor, University of Colorado School of Medicine
在 cpcmed.org 的电子邮件经过验证
标题
引用次数
年份
1. Ali MJ, Davison PD, Pickett W, Ali NS: ACC/AHA guidelines as predictors of postoperative cardiac outcomes. Canadian Journal of Anaesthesia 47 (2000) 10-19
WR Hiatt, M Hunink, J Isner, J Lammer, L Norgren, J Novo, B Ricco, ...
surgery 135, 847-857, 2001
2001
17 CHAPTER Pathophysiology of Peripheral Artery Disease, Intermittent Claudication, and Critical Limb Ischemia
WR Hiatt, EP Brass
Vascular Medicine E-Book: A Companion to Braunwald's Heart Disease, 223, 2012
2012
2143 Extracorporeal Shock Waves Versus Botulinum Toxin Type A in the Treatment of Poststroke Upper Limb Spasticity: A Randomized Noninferiority Trial
YT Wu, HK Yu, LR Chen, CN Chang, YM Chen, GC Hu, AF Moraska, ...
2259 Ticagrelor in patients wtih symptomatic peripheral artery disease and prior coronary artery disease
J Berger, G Heizer, I Baumgartner, FGR Fowkes, P Held, BG Katona, ...
European Heart Journal 38 (suppl_1), ehx502. 2259, 2017
2017
238 A randomized, double-blind placebo-controlled study of NV1FGF gene therapy in critical limb ischemia patients (TAMARIS Study): Rationale, design and baseline patient …
E Van Belle, S Nikol, L Norgren, I Baumgartner, V Driver, W Hiatt, J Bech
Archives of Cardiovascular Diseases Supplements 3 (1), 77-78, 2011
12011
4065 Moderate to severe renal insufficiency and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: the EUCLID trial
CW Hopley, S Kavanagh, M Patel, I Baumgartner, JS Berger, JI Blomster, ...
European Heart Journal 39 (suppl_1), ehy563. 4065, 2018
2018
6-minute Walk Test Variability May be Reduced by a Structured Training and Monitoring Program, Potentially Facilitating Detection of Treatment Effects
JA Hsia, MP Bonaca, R White, V Anderson, WR Hiatt
Circulation 142 (Suppl_3), A13462-A13462, 2020
2020
A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association
AT Hirsch, MA Allison, AS Gomes, MA Corriere, S Duval, AG Ershow, ...
Circulation 125 (11), 1449-1472, 2012
3572012
A comparison of cilostazol and pentoxifylline for treating intermittent claudication
DL Dawson, BS Cutker, WR Hiatt
ACC Current Journal Review 3 (10), 29-30, 2001
32001
A comparison of cilostazol and pentoxifylline for treating intermittent claudication
DL Dawson, BS Cutler, WR Hiatt, RW Hobson, JD Martin, EB Bortey, ...
1999
A comparison of cilostazol and pentoxifylline for treating intermittent claudication
DL Dawson, BS Cutler, WR Hiatt, RW Hobson II, JD Martin, EB Bortey, ...
The American journal of medicine 109 (7), 523-530, 2000
6132000
A comparison of cilostazol and pentoxifylline for treating intermittent laudication
DL Dawson, BS Cutler, WR Hiatt
ACP JOURNAL CLUB 134 (3), 105-105, 2001
2001
A Contemporary Assessment of Lipid Lowering Therapies and Low-density Lipoprotein Cholesterol in Peripheral Artery Disease
CN Hess, CP Cannon, JA Beckman, P Goodney, MR Patel, E Shannon, ...
Circulation 142 (Suppl_3), A14141-A14141, 2020
2020
A critical review of antiplatelet treatment in peripheral arterial disease
F Violi, W Hiatt
Internal and Emergency Medicine 2, 84-87, 2007
72007
A high ankle brachial index is associated with increased cardiovascular disease morbidity and worse quality of life
MA Allison, MH Criqui, WR Hiatt, AT Hirsch
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 49 (9), 405A-405A, 2007
12007
A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life
MA Allison, WR Hiatt, AT Hirsch, JR Coll, MH Criqui
Journal of the American College of Cardiology 51 (13), 1292-1298, 2008
2332008
A model-based approach to analyzing ankle-brachial index: Results from the action for health in diabetes study group
MA Espeland, JG Regensteiner, WR Hiatt, LE Wagenknecht, J Bahnson, ...
CIRCULATION 113 (8), E357-E357, 2006
2006
A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER TRIAL OF THE SAFETY AND EFFICACY OF PLASMID DNA EXPRESSING 2 ISOFORMS OF HEPATOCYTE GROWTH FACTOR IN …
EC Perin, F Mendelsohn, M Davies, H Pham, J Saucedo, A Hirsch, ...
Journal of the American College of Cardiology 63 (12S), A2092-A2092, 2014
22014
A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication
EP Brass, LT Cooper, RE Morgan, WR Hiatt
Journal of vascular surgery 55 (2), 381-389. e1, 2012
272012
A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication
RL Pande, WR Hiatt, P Zhang, N Hittel, MA Creager
Vascular medicine 15 (3), 181-188, 2010
1342010
系统目前无法执行此操作,请稍后再试。
文章 1–20